These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subsquamous intestinal metaplasia after ablation of Barrett's esophagus: frequency and importance. Mashimo H Curr Opin Gastroenterol; 2013 Jul; 29(4):454-9. PubMed ID: 23674187 [TBL] [Abstract][Full Text] [Related]
3. Subsquamous extension of intestinal metaplasia is detected in 98% of cases of neoplastic Barrett's esophagus. Anders M; Lucks Y; El-Masry MA; Quaas A; Rösch T; Schachschal G; Bähr C; Gauger U; Sauter G; Izbicki JR; Marx AH Clin Gastroenterol Hepatol; 2014 Mar; 12(3):405-10. PubMed ID: 23891922 [TBL] [Abstract][Full Text] [Related]
4. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948 [TBL] [Abstract][Full Text] [Related]
5. Allaying uncertainty in diagnosing buried Barrett's esophagus. Demkowicz R; Thota PN; Benjamin T; Lopez R; Lu H; Patil DT; Downs-Kelly E; Jeung JA; Lai KK; Lapinski J; Savage EC; Goldblum JR; Gordon IO Ann Diagn Pathol; 2021 Apr; 51():151672. PubMed ID: 33418428 [TBL] [Abstract][Full Text] [Related]
6. A human Barrett's esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts. Zhang Q; Bansal A; Dunbar KB; Chang Y; Zhang J; Balaji U; Gu J; Zhang X; Podgaetz E; Pan Z; Spechler SJ; Souza RF Am J Physiol Gastrointest Liver Physiol; 2022 Jun; 322(6):G598-G614. PubMed ID: 35380457 [TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus and intestinal metaplasia of gastric cardia: prevalence, clinical, endoscopic and histological features. Pascarenco OD; Boeriu A; Mocan S; Pascarenco G; Drasoveanu S; Galeanu M; Dobru D J Gastrointestin Liver Dis; 2014 Mar; 23(1):19-25. PubMed ID: 24689092 [TBL] [Abstract][Full Text] [Related]
8. Subsquamous intestinal metaplasia is common in treatment-naïve Barrett's esophagus. Bartel MJ; Srivastava A; Gordon S; Rothstein RI; Pohl H Gastrointest Endosc; 2018 Jan; 87(1):67-74. PubMed ID: 28687439 [TBL] [Abstract][Full Text] [Related]
9. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus. Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390 [TBL] [Abstract][Full Text] [Related]
10. Markers suggest reduced malignant potential of subsquamous intestinal metaplasia compared with Barrett's esophagus. Basavappa M; Weinberg A; Huang Q; Mashimo H Dis Esophagus; 2014 Apr; 27(3):262-6. PubMed ID: 23796148 [TBL] [Abstract][Full Text] [Related]
11. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD]. Endzinas Z; Mickevicius A; Kiudelis M Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039 [TBL] [Abstract][Full Text] [Related]
12. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia? Morales TG; Bhattacharyya A; Johnson C; Sampliner RE Am J Gastroenterol; 1997 Oct; 92(10):1818-22. PubMed ID: 9382043 [TBL] [Abstract][Full Text] [Related]